ARTICLE | Company News
Pharmos other research news
July 15, 1996 7:00 AM UTC
PARS received a $1 million grant from the U.S. Binational Industrial Research Development Foundation (BIRD) to develop a product containing PARS's Lotemax site-active steroid combined with tobramycin....